The US Federal Trade Commission has filed a lawsuit against several pharmaceutical companies for delaying the release of a cheaper form of a medication, a conspiracy known as pay-for-delay agreements.
Reports say the FTC filed its suit against brand name pharmaceutical companies AbbVie and Besins Healthcare, as well as against generic maker Teva Pharmaceuticals, with accusations the companies agreed to delay the release of the generic form of a testosterone replacement therapy cream. In pay-for-delay agreements, brand name companies pay their generic counterparts from delaying the release of their cheaper drugs for sale.
The FTC’s allegations include claims of restraint of trade against companies.
In the wake of a high-profile pay-for-delay case that reached the US Supreme Court, FTC v. Actavis, a precedent was set that determined large cash settlement pay-for-delay deals were anticompetitive.
Now, the industry is awaiting a ruling by the US Court of Appeals for the Third Circuit, which will hear the appeal of a lawsuit that was dismissed because the pay-for-delay deal did not involve a cash settlement.
Full content: The Legal Intelligencer
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI